Lineage Cell Therapeutics (LCTX) Stock Chart & Stock Price History $1.28 +0.08 (+6.67%) Closing price 04:10 PM EasternExtended Trading$1.27 -0.01 (-0.78%) As of 05:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock Lineage Cell Therapeutics Stock Price Performance The Lineage Cell Therapeutics (LCTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 48.77%, with a year-to-date return of 154.73%. In the past month, the stock has increased 33.21%, reflecting recent market activity. As of the latest close, Lineage Cell Therapeutics traded at $1.20 with a market cap of $274.03 million and volume of 7.41 million shares. Five years ago, the stock traded at $0.93, representing a 37.68% increase over that period. At the time, it had a market cap of $137.22 million and a volume of 557,941 shares. Receive LCTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lineage Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+24.27%1 Month Performance+33.21%3 Month Performance+176.46%Year-To-Date Performance+154.73%1 Year Performance+48.77%5 Year Performance+37.68% LCTX Stock Chart for Monday, August, 18, 2025 LCTX Chart by TradingView Lineage Cell Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/15/2025$1.02$1.20+17.65%$1.31$1.037.41 million shs$274.03 million08/14/2025$1.03$1.02-0.97%$1.05$1.00832,482 shs$232.93 million08/13/2025$1.01$1.03+1.98%$1.05$0.971.22 million shs$235.21 million08/12/2025$1.01$1.01$1.05$0.991.16 million shs$230.64 million08/11/2025$0.98$1.01+2.60%$1.05$0.98962,317 shs$230.64 million08/08/2025$0.95$0.98+3.53%$1.00$0.95657,585 shs$224.80 million08/07/2025$0.99$0.95-3.95%$1.02$0.951.01 million shs$217.13 million08/06/2025$0.96$0.99+3.18%$1.02$0.961.06 million shs$226.05 million08/05/2025$0.97$0.96-1.09%$1.00$0.95788,886 shs$219.09 million08/04/2025$0.99$0.97-1.55%$1.02$0.95987,997 shs$221.51 million Get the Latest News and Ratings for LCTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lineage Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/01/2025$1.02$0.99-3.40%$1.04$0.962.00 million shs$225.00 million07/31/2025$1.03$1.02-0.97%$1.09$1.01820,421 shs$232.93 million07/30/2025$1.07$1.03-3.74%$1.08$1.001.58 million shs$235.21 million07/29/2025$1.17$1.07-8.55%$1.18$1.071.86 million shs$244.35 million07/28/2025$1.13$1.17+3.54%$1.21$1.131.82 million shs$267.18 million07/25/2025$1.15$1.13-1.74%$1.21$1.121.67 million shs$258.05 million07/24/2025$1.08$1.15+6.48%$1.18$1.033.71 million shs$262.61 million07/23/2025$0.95$1.08+13.68%$1.10$0.962.39 million shs$246.63 million07/22/2025$0.94$0.95+0.60%$0.97$0.93912,310 shs$216.94 million07/21/2025$0.96$0.94-1.73%$1.02$0.941.25 million shs$215.64 million07/18/2025$0.99$0.96-2.94%$1.01$0.951.46 million shs$219.43 million07/17/2025$1.02$0.99-2.94%$1.05$0.991.59 million shs$226.08 million Related Companies Enliven Therapeutics Stock Price Chart Upstream Bio Stock Price Chart Anavex Life Sciences Stock Price Chart Sionna Therapeutics Stock Price Chart Zymeworks Stock Price Chart Basilea Pharmaceutica Stock Price Chart Akebia Therapeutics Stock Price Chart Trevi Therapeutics Stock Price Chart Mineralys Therapeutics Stock Price Chart Urogen Pharma Stock Price Chart Receive LCTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lineage Cell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NYSEAMERICAN:LCTX) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lineage Cell Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lineage Cell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access